Literature DB >> 18563346

Ultrasound-guided thrombin injection: an alternative treatment for femoral artery pseudoaneurysm with better efficiency and safety.

Qinghai Yao1, Hongliang Cong, Shangqin Wu, Shan Sun, Qike Dong, Dongmei Chen, Peng Li.   

Abstract

The aim of this study was to evaluate the efficiency and safety of ultrasound-guided thrombin injection on femoral pseudoaneurysm (FPA) as compared to ultrasound-guided local oppression. Eleven cases of FPA were enrolled and 7 cases received ultrasound-guide thrombin injection (injection group), and the remaining 4 cases were treated with local oppression (oppression group). Efficiency and safety were analyzed by ultrasound and subsequent follow-up. The results showed that 1 case relapsed in oppression group while no relapse occurred in thrombin injection group. Ultrasound-guided thrombin injection is better for treatment of FPA in terms of effectiveness and safety.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563346     DOI: 10.1007/s11596-008-0334-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  4 in total

1.  The efficacy of ultrasound-guided compression of iatrogenic femoral pseudo-aneurysms.

Authors:  P Lange; T Houe; U J Helgstrand
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-03       Impact factor: 7.069

2.  Ruptured femoral pseudo-aneurysm through the skin: a rare vexing complication following aortobifemoral reconstruction.

Authors:  J De Raet; J Vandekerkhof; I Baeyens
Journal:  Acta Chir Belg       Date:  2006 Jul-Aug       Impact factor: 1.090

Review 3.  Iatrogenic pseudoaneurysm of femoral artery: case report and literature review.

Authors:  Martina Lenartova; Tahir Tak
Journal:  Clin Med Res       Date:  2003-07

4.  Comparison of 4 and 6 French catheters for coronary angiography: real-world modeling.

Authors:  Ronen Durst; Chaim Lotan; Hisham Nassar; Mervin Gotsman; Eli Mor; Boris Varshitzki; Penko Greganski; Refat Jabara; Dan Admon; David Meerkin; Morris Mosseri
Journal:  Isr Med Assoc J       Date:  2007-04       Impact factor: 0.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.